Physician profile
Abhilash Nair
NPI 1215147103
$1,378.19
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,241 · 2020: $96.18 · 2021: $15.67 · 2022: $25.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veran Medical Technologies, INC. | $835.29 | 2019 | |
| Glaxosmithkline, LLC. | $128.90 | 2019-2020 | |
| Allergan, INC. | $127.94 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $71.14 | 2019 | |
| Electromed, INC. | $43.70 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $25.55 | 2022 | |
| Grifols USA, LLC | $24.68 | 2019 | |
| Sunovion Pharmaceuticals INC. | $24.68 | 2019 | |
| Osiris Therapeutics INC. | $20.15 | 2019 | |
| Vanda Pharmaceuticals INC. | $19.74 | 2020 | |
| Merck Sharp & Dohme LLC | $17.50 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.00 | 2019 | |
| Pulmonx Corporation | $10.98 | 2020 | |
| Smith+Nephew, INC. | $10.94 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhilash Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.